Managing cardiovascular disease risk in hypertension
Lancet
.
2020 Mar 14;395(10227):869-870.
doi: 10.1016/S0140-6736(20)30048-9.
Authors
Richard McManus
1
,
Margaret Constanti
2
,
Christopher N Floyd
3
,
Mark Glover
4
,
Anthony S Wierzbicki
5
;
National Institute for Health and Care Excellence Hypertension (NG136) Guideline Development Group
Affiliations
1
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
2
National Clinical Guidelines Centre, Royal College of Physicians, London NW1 4LE, UK (MC). Electronic address: margaret.constanti@rcplondon.ac.uk.
3
Department of Clinical Pharmacology, King's College London, London, UK (CNF).
4
The Division of Therapeutics and Molecular Medicine, University of Nottingham, Nottingham, UK (MG).
5
Department of Metabolic Medicine and Chemical Pathology, Guy's and St Thomas' Hospitals, London, UK (ASW).
PMID:
32171410
DOI:
10.1016/S0140-6736(20)30048-9
No abstract available
Publication types
Letter
Comment
MeSH terms
Blood Pressure
Blood Pressure Determination
Cardiovascular Diseases*
Humans
Hypertension*
Retrospective Studies